Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Treasury Shares: 2015-2024

Historic Treasury Shares for Assembly Biosciences (ASMB) over the last 6 years, with Dec 2024 value amounting to $68,054.

  • Assembly Biosciences' Treasury Shares fell 28.50% to $68,054 in Q4 2024 from the same period last year, while for Dec 2024 it was $68,054, marking a year-over-year decrease of 28.50%. This contributed to the annual value of $68,054 for FY2024, which is 28.50% down from last year.
  • According to the latest figures from Q4 2024, Assembly Biosciences' Treasury Shares is $68,054, which was down 28.50% from $95,182 recorded in Q4 2023.
  • In the past 5 years, Assembly Biosciences' Treasury Shares registered a high of $1.8 million during Q3 2022, and its lowest value of $68,054 during Q4 2024.
  • For the 3-year period, Assembly Biosciences' Treasury Shares averaged around $868,699, with its median value being $829,076 (2022).
  • The largest annual percentage gain for Assembly Biosciences' Treasury Shares in the last 5 years was 102.81% (2022), contrasted with its biggest fall of 85.41% (2022).
  • Over the past 5 years, Assembly Biosciences' Treasury Shares (Quarterly) stood at $886,868 in 2020, then grew by 9.41% to $970,339 in 2021, then crashed by 85.41% to $141,544 in 2022, then tumbled by 32.75% to $95,182 in 2023, then declined by 28.50% to $68,054 in 2024.
  • Its Treasury Shares stands at $68,054 for Q4 2024, versus $95,182 for Q4 2023 and $141,544 for Q4 2022.